Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.930
+0.030 (1.58%)
Jun 6, 2025, 4:00 PM - Market closed

APUS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1.5-1.39-0.78-0.67-1.03
Stock-Based Compensation
--0.070.190.19
Other Operating Activities
0.130.120.040.030.01
Change in Accounts Payable
0.880.540.05-00
Change in Other Net Operating Assets
00-0.010-0
Operating Cash Flow
-0.49-0.73-0.63-0.45-0.82
Short-Term Debt Issued
-0.330.010.28-
Long-Term Debt Issued
----0.4
Total Debt Issued
0.590.330.010.280.4
Short-Term Debt Repaid
---0.03--
Total Debt Repaid
---0.03--
Net Debt Issued (Repaid)
0.590.33-0.020.280.4
Issuance of Common Stock
--1.06--
Financing Cash Flow
0.590.331.030.280.4
Net Cash Flow
0.1-0.410.4-0.17-0.42
Levered Free Cash Flow
-0.02-0.29-0.35-0.2-
Unlevered Free Cash Flow
0.06-0.22-0.32-0.18-
Change in Net Working Capital
-0.92-0.58-0.07-0.03-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q